COMPANY · NIPC 513481613

Vertex Pharmaceuticals Unipess

This page shows the public contracts the company has signed, which bodies gave them, and who it competed against.

Portal BASE records €225,903,686.04 across 265 contracts.

Follow (RSS) · What is RSS?

Identification

Company nameVertex Pharmaceuticals Unipess
NIPC513481613
Registered officeRUA TOMAS FONSECA, TORRE G, 1600-209 LISBOA
SourceTED (Jornal Oficial da UE), aviso 93354-2025
Record date11 February 2025

Contracted money

Sums of the contract prices on Portal BASE. A contract with several buyers or municipalities counts once in each row, so rows do not add up to the total.

Contracted value by yearBars with the value contracted in each year, from 2018 to 2026. The table below gives the same values.2018: €339,980.0320182019: €351,551.462020: €493,900.0420202021: €8,295,899.892022: €33,911,418.5920222023: €39,869,324.492024: €44,537,623.0320242025: €49,846,666.332026: €48,257,322.182026€49,846,666.33
Contracted value by year
YearContractsContract value
20183€339,980.03
20193€351,551.46
20204€493,900.04
202141€8,295,899.89
202235€33,911,418.59
202343€39,869,324.49
202448€44,537,623.03
202544€49,846,666.33
202644€48,257,322.18
Contracted value by place of performance
NameContractsContract value
Lisboa97€102,158,314.49
Porto89€69,305,004.86
Coimbra48€45,095,839.11
Funchal26€7,064,100.91
Largest contracts
SubjectYearContract value
Aquisição de Moduladores CFTR no tratamento da Fibrose Quística para o ano de 20242024€9,159,574.88
231G000543-Aquisição de Medicamentos Diversos Ano de 20232023€8,668,066.20
Ajuste direto para aquisição de I1176 - IVACAFTOR [150 MG; CÁP/ COMP]; I1177 - IVACAFTOR + TEZACAFTOR + ELEXACAFTOR [75 + 50 + 100 MG; CÁP/ COMP]; I1252 - IVACAFTOR [75 MG; CÁP/COMP]; I1253 - IVACAFTOR [75 MG;GRAN]; I1254 - IVACAFTOR [50 MG2025€7,740,618.98
040109242025 - 1328/2025 Ajuste direto para aquisição de I1176 - IVACAFTOR [150 MG; CÁP/ COMP]; I1177 - IVACAFTOR + TEZACAFTOR + ELEXACAFTOR [75 + 50 + 100 MG; CÁP/ COMP]; I1252 - IVACAFTOR [75 MG; CÁP/COMP]; I1253 - IVACAFTOR [75 MG;GRAN];2025€7,644,272.32
Ajuste direto para aquisição de I1176 - IVACAFTOR [150 MG; CÁP/ COMP]; I1177 - IVACAFTOR + TEZACAFTOR + ELEXACAFTOR [75 + 50 + 100 MG; CÁP/ COMP]; I1252 - IVACAFTOR [75 MG; CÁP/COMP]; I1253 - IVACAFTOR [75 MG;GRAN]; I1254 - IVACAFTOR [50 MG2025€7,610,732.25

Who they competed with

In 120 contracts with a list of competitors, the company took part and was awarded 120 (100%).

The annual IMPIC file lists competitors for about 42% of contracts. Only these enter the counts, and the award share is measured on them.

Links read in contract documents

Contract documents give addresses and the names of representatives and partners, and Portal BASE and GLEIF give competitors and groups. This is what the records show; the same address or name can have simple explanations.

The documents we read show no links between these companies.

Investigations that mention it

No published investigation mentions this company by NIPC.